Section of Contact Dermatitis, Division of Dermatology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 10400.
Dermatitis. 2010 Jul-Aug;21(4):203-6.
Corticosteroid allergy is a complication of topical therapy detected by patch-testing with corticosteroid allergens.
Ten-year retrospective review to study the prevalence and patterns of corticosteroid allergy in Thai patients.
Of 882 patients who were patch-tested, 29 (3.29%) had allergic reactions to corticosteroids. Of these 29 patients, 17 (58.62%) had positive reactions to one corticosteroid, and 12 (41.38%) reacted to multiple corticosteroids. Rates of reaction to corticosteroid groups ranged from 31.03 to 80.95%. Concomitant reactions between groups were noted. The prevalence of topical corticosteroid allergy (using two screening allergens, tixocortol pivalate and budesonide) was 2.27% (20 of 882). Testing with additional steroid allergens in suspected cases increased the prevalence to 3.29%. Tixocortol pivalate detected 51.72% of corticosteroid-allergic cases, and budesonide detected 24.14%. Combining both tixocortol and budesonide detected 68.97% of cases.
Corticosteroid allergy is found to multiple corticosteroids, and concomitant reactions occur across groups. Group D1 corticosteroid esters produced a higher positive reaction rate (61.9%) than groups D2 (52.38%) and A (51.72%). This may be due to different prescribing habits or the easy access to D1 corticosteroids sold over the counter by pharmacies in Thailand.
皮质类固醇过敏是通过皮质类固醇变应原斑贴试验检测到的局部治疗的并发症。
对泰国患者进行了为期 10 年的回顾性研究,以研究皮质类固醇过敏的患病率和模式。
在 882 例接受斑贴试验的患者中,有 29 例(3.29%)对皮质类固醇过敏。这 29 例患者中,17 例(58.62%)对一种皮质类固醇有阳性反应,12 例(41.38%)对多种皮质类固醇有反应。皮质类固醇组的反应率从 31.03%到 80.95%不等。还观察到组间的伴随反应。使用两种筛选变应原(倍他米松戊酸酯和布地奈德),局部皮质类固醇过敏的患病率为 2.27%(882 例中的 20 例)。在疑似病例中增加皮质类固醇变应原检测,患病率增加到 3.29%。倍他米松戊酸酯检测到 51.72%的皮质类固醇过敏病例,布地奈德检测到 24.14%。联合使用倍他米松戊酸酯和布地奈德检测到 68.97%的病例。
皮质类固醇过敏可发生于多种皮质类固醇,并且组间会发生伴随反应。D1 皮质类固醇酯产生的阳性反应率(61.9%)高于 D2(52.38%)和 A(51.72%)。这可能是由于不同的处方习惯,或者由于泰国药店容易获得 D1 皮质类固醇的非处方销售。